Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04191655 · ClinicalTrials.gov registry record · NA
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT04191655 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 211 participants.
The verdict
NCT04191655, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
Inflammatory Bowel Disease (IBD) involving the colon is a known risk for colon cancer. There are two standards-of-care colonoscopy techniques used for screening all patients who suffer from IBD for more than eight years. One method is to obtain random biopsies throughout the colon and the other is by using dye spraying chromo-colonoscopy. This trial aims to study the difference between the two colonoscopy techniques during the era of high definition camera in detecting neoplastic lesions during screening patients with long-standing IBD.
Interventions
- DEVICE High Definition Colonoscopy
- DEVICE Dye Spraying Chromocolonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2024-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04191655
The ClinicalTrials.gov registry entry for NCT04191655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Definition Colonoscopy is the first listed.
NCT04191655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04191655 about?
NCT04191655 is a clinical study titled "High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)". Inflammatory Bowel Disease (IBD) involving the colon is a known risk for colon cancer. There are two standards-of-care colonoscopy techniques used for screening all patients who suffer from IBD for more than eight years. One method is to obtain random biopsies throughout the colon and the other is b...
What is the current status of trial NCT04191655?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2019-04-03. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT04191655?
The interventions under investigation include: High Definition Colonoscopy (DEVICE), Dye Spraying Chromocolonoscopy (DEVICE).
Who is sponsoring clinical trial NCT04191655?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.